Breast cancer (BC) is the most prevalent cancer type in the UK, with one in seven women being diagnosed in their lifetime1. The World Health Organization (WHO) reported that 2.3 million women were diagnosed with BC in 20202. While there has been a significant rise in the occurrence of BC over the past 20 years, the mortality rate has been reduced, in part, by the implementation of screening3.
Yet, although preventative measures provide clinical management before diagnosis, the quality of life (QoL) of BC patients during treatment is deteriorating4. QoL is defined by the WHO as “individuals’ perceptions of their position in life in the context of the culture and value systems in which they live and about their goals, expectations, standards and concerns”5. This encompasses aspects of an individual’s wellbeing, including physical health, psychological...
Sign in to your account
Log in
This content is available to registered users only. Please sign in to continue.
If you are not yet registered, please create your account on www.sor.org and verify your membership status. Once your account has been set up, return here and sign in to access the content.
Set up your account